Troy Lister, Chief Scientific Officer at Verve Therapeutics, Inc. (VERV), sold 2,189 shares at $4.15 ($9K) on 2025-04-02, disclosed to the SEC on 2025-04-03.
Open-market sale of $9k VERV by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.